Prevalence & Survival Rate Ovarian cancer is the fifth according to the frequency of deaths caused by cancer in women, the leading cause of deaths caused by malignant gynecologic tumors, and the second according to the frequency of tumors in gynecology. Every year at least 225 thousand cases of...
Ovarian cancer is difficult to diagnose because symptoms often do not occur until late in the disease. Symptoms do not occur until the tumor has grown large enough to apply pressure to other organs in the abdomen, or until the cancer has spread to remote organs. The symptoms are nonspecific,...
The five-year survival rate is extremely high for patients with localized ovarian cancers and for those whose ovarian cancers are diagnosed and treated early. Those women often go on to live long, healthy lives. However, the rate for all stages combined is under 50 percent, and stage IV ovar...
SURVIVAL rateOVARIAN cancerGYNECOLOGIC cancerDELAYED diagnosisSYMPTOMSDEATH rateOvarian cancer is amongst one of the most commonly occurring cancers affecting women, and the leading cause of gynecologic related cancer death. Its poor prognosis and high mortality rates can be attributed to the absence of ...
Numerous studies link asbestos exposure to ovarian cancer. Women with a history of asbestos exposure have higher rates of ovarian cancer.
Every year about quarter of a million women around the world are diagnosed with ovarian cancer and 140,000 women die of it, making it the cancer for women with the lowest survival rate. Due to a widespread lack of awareness and the absence of early screening tests many cases of ovarian ca...
Over the past two decades, the 5-year survival for ovarian cancer patients has substantially improved owing to more effective surgery and treatment with empirically optimized combinations of cytotoxic drugs, but the overall cure rate remains approximately 30%. Many investigators think that further empiri...
Extended follow-up data may help clarify this potential finding in the future; however, given the aggressive nature (ie, low 5-year survival rate) of ovarian cancer, the mechanism behind a delayed benefit from screening and early detection would be unclear, especially because the trial ...
cancer (EOC) represents 95% of all malignant ovarian neoplasms[2]. The most lethal subtype is high-grade serous EOC, representing 70% to 75% of all cases of ovarian carcinoma[3,4]. This subtype usually presents at a late stage, resulting in a 5-year overall survival rate of 35%[5]....
Ovarian cancer has the highest mortality rate among gynecologic tumors, with a 5-year survival rate of less than 25%. There is an urgent need for early diagnosis and new drugs to reduce the disease burden of ovarian cancer. The aim of this study was to i